Boardroom Alpha
Boardroom Alpha
CNK · Current Report (Form 8-K) · Filed September 5, 2025

Cinemark Holdings Inc — Current Report (Form 8-K)

Form
8-K
Filed
September 5, 2025
Period
Sep 5, 2025
Ticker
CNK
Accession
0001193125-25-197288
Boardroom Alpha · Filing insights

Cinemark amended its credit facility: revolver to $225M, 1.50% rate reduction, maturity in 2028.

About Cinemark Holdings Inc
Market cap
$3.6B
1Y TSR
−13.2%
3Y TSR
+17.7%
Board grade
B-
Sector
Communication Services
CEO
Sean Gamble
Last annual meeting: May 14, 2026 · View full Cinemark Holdings Inc profile →
8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 5, 2025
 
 
 
Commission
File Number
 
Exact Name of Registrant as
Specified in its Charter,
Principal Executive Office Address
and Telephone Number
 
State of
Incorporation
  
IRS Employer
Identification No.
001-33401
 
Cinemark Holdings, Inc.
3900 Dallas Parkway
Plano, Texas 75093
(972)
665-1000
 
Delaware
  
20-5490327
033-47040
 
Cinemark USA, Inc.
3900 Dallas Parkway
Plano, Texas 75093
(972)
665-1000
 
Texas
  
75-2206284
 
 
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
 
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
 
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
   
Title of each class
 
Trading
symbol(s)
  
Name of each exchange
on which registered
Cinemark Holdings, Inc.   Common Stock, par value $0.001 per share   CNK   
NYSE
NYSE Texas
Cinemark USA, Inc.   None   None    None
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 

Item 1.01 Entry into a Material Definitive Agreement.
On September 5, 2025, Cinemark Holdings, Inc. (“
we
”, “
our
”, “
us
”) and Cinemark USA, Inc. (“
Cinemark USA
”), our wholly-owned subsidiary, entered into a Fourth Amendment (the “
Fourth Amendment
”) to the Second Amended and Restated Credit Agreement, dated as of May 26, 2023 (as amended by that certain First Amendment, dated as of May 28, 2024, that certain Second Amendment, dated as of November 29, 2024, and that certain Third Amendment, dated as of June 30, 2025, the “
Credit Agreement
”), among us, Cinemark USA, the several banks and other lenders from time to time party thereto, the other agents and arrangers named therein and Barclays Bank PLC, as administrative agent. The Credit Agreement was amended pursuant to the Fourth Amendment to, among other things, reduce the rate at which the revolving loans bear interest by 1.50% and increase the aggregate commitment of the revolving loans available to us by an amount equal to $100,000,000 (to a total aggregate commitment of revolving loans equal to $225,000,000). The revolving credit facility is scheduled to mature on May 26, 2028, subject to a springing maturity date of April 15, 2028 in certain circumstances, and Cinemark USA will be required to pay a commitment fee calculated at a percentage ranging from 0.25% to 0.375% on the average daily unused portion of the revolving credit facility, payable quarterly in arrears.
The foregoing summary of the Fourth Amendment is qualified in its entirety by reference to the complete copy of the Fourth Amendment, filed as Exhibit 10.1 to this Current Report on Form
8-K
and is incorporated by reference herein.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance
Sheet Arrangement of Registrant.
The information set forth in Item 1.01 above is hereby incorporated into this Item 2.03.
Item 9.01 Financial Statements and Exhibits.
 
(d)
Exhibits
 
Exhibit No.
  
Exhibit Description
10.1    Fourth Amendment, dated as of September 5, 2025, to the Second Amended and Restated Credit Agreement, dated as of May 26, 2023 (as amended by that certain First Amendment, dated as of May 28, 2024, that certain Second Amendment, dated as of November 29, 2024, and that certain Third Amendment, dated as of June 30, 2025), among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other lenders from time to time party thereto, the other agents and arrangers named therein and Barclays Bank PLC, as administrative agent.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)
 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  CINEMARK HOLDINGS, INC.
  CINEMARK USA, INC.
Date: September 5, 2025   By:  
/s/ Michael D. Cavalier
    Name:   Michael D. Cavalier
    Title:   Executive Vice President - General Counsel and
      Business Affairs & Secretary
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cinemark Holdings Inc (CNK)

Reference

Frequently asked questions

When did Cinemark Holdings Inc file this 8-K?
Cinemark Holdings Inc (CNK) filed this Current Report (Form 8-K) with the SEC on September 5, 2025. The accession number assigned by EDGAR is 0001193125-25-197288.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Cinemark amended its credit facility: revolver to $225M, 1.50% rate reduction, maturity in 2028. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cinemark Holdings Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cinemark Holdings Inc has filed under CIK 1385280, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer